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278 Improving homecare for people with cystic ﬁbrosis in South East
England
H.A. Wyatt1, C. Gardner2, M. Korkodilos2, B. Rana3. 1King’s College Hospital,
Department of Child Health, London, United Kingdom; 2London Specialist
Commissioning Group, Audit, Information and Analysis Unit (AIAU), London,
United Kingdom; 3South East Coast Specialist Commissioning Group, Aylesford,
Kent, United Kingdom
Objectives: South East Coast Specialised Commissioning Group (SEC-SCG) is
responsible for people with CF living in Kent, Surrey, Sussex. Paediatric care is
from two Specialist Centres and their network clinics, any of which may prescribe
home intravenous antibiotics (HIVAB). No standards or guidelines for provision of
homecare services exist but concerns about the quality of HIVAB process led to an
audit by AIAU for SEC-SCG.
Methods: Parents/carers, commissioners and clinicians designed an audit question-
naire for carers about their experiences. Adult patients were also surveyed but aren’t
included in results below. 67 children were identiﬁed and 27 (40%) questionnaires
returned. HIVAB were provided by a number of sources. 18 (67%) carers were
satisﬁed but signiﬁcant issues were raised:
• 13 (48%) had no home visit prior to ﬁrst course of HIVAB
• 4 (15%) had not personally administered IV antibiotics before discharge for ﬁrst
course of HIVAB and had not felt conﬁdent
• 24 children had multiple courses of HIVAB but technique was reviewed in only
13 (54%)
• No routine written instructions
• 11 (41%) of those given Epipens had expired devices
• 9 (33%) patients had no monitoring
• 11 (41%) had no access to a physiotherapist
• 9 (33%) had no clear out of hours point of contact
• 2 (7%) felt their child would have beneﬁted from admission rather than HIVAB
• 10 (36%) had run out of drugs, and 12 (44%) had run out of consumables
Conclusions:
1. Whilst imperfect recall or understanding may be relevant, carers’ perception of
HIVAB is of concern
2. Quality of HIVAB service was variable and had shortfalls
3. Gaps in education, training and support of carers were identiﬁed
4. Clinical monitoring of HIVAB needs enhancing
279 A quality improvement program (QIP) aimed at improving
nutritional status of CF patients aged 2−12 years old over a
3 year period at CF Centre Roscoff
K. Revert-Murnaghan1, J. Pengam1, M.-L. Madec1, L. Audran1, S. Jaffrennou1,
L. Maitrallain1, A. Naud1, P. Lesne1. 1Centre de Perharidy, CF Centre, Roscoff
Cedex, France
Background: Based on the North American experience to reduce inequality of
care and life expectancy between US CF centres, Roscoff CF centre enrolled in
the French QIP in June 2011 and created a team responsible for carrying out the
program.
Objectives: To attain a mean BMI Z-score = 0 in CF patients aged 2−12 and thus
improve the mean FEV1 in this population.
Methods: % FEV1 and BMI Z-scores (in 2010) were analysed for 139 patients
(adults and children) followed up at Roscoff CF centre. The target population
of children aged 2−12 (n = 34) was selected as the intervention group as BMI
Z-score varied from −3.5 to +1.8 (mean −0.5). A new intensiﬁed process was
elaborated according to guidelines. Children were classiﬁed in different colour
groups according to their BMI Z-score. In addition to shared baseline care,
the number of consultations with a dietician, calorie-intake evaluations, stool fat
analyses, prescription of oral supplements was decided according to the colour
category. The signiﬁcant relationship between nutritional status and FEV1 was
illustrated for children and parents with results from large American studies.
Each child/parent received a colour-coded BMI curve with the child’s path and
actual position on the chart as well as a 100 calorie-equivalent snack suggestion
sheet. Home weekly weighing, individualised weight gain objectives, psychological
follow up and discussion about G tube feeding were items included for the more
severe groups.
Conclusions: Initial results show that children and parents were interested in the
program and motivated by this more intensive procedure. Five-month follow up
results will be illustrated on the poster.
280 CF quality improvement program in France: the pilot experience
of Paris Robert Debre´ Centre
M. Ge´rardin1, E. Carde1, A. Vital Foucher1, A. Pesle1, S. Catto1, A. Munck1.
1Hospital Robert Debre´, Paris, France
Background: Quality improvement programs (QIP) optimize patients’ outcomes
and increase satisfaction of both the patient and the professionals.
Objectives: Contribution of a paediatric QIP pilot phase (Program PHARE-M) to
ascertain applicability and adapt the QIP approach (© 2001 Trustees of Dartmouth
College, Godfrey, Nelson, Batalden © 2006, Cystic Fibrosis Foundation), for full
team ownership; the one year global pilot work has involved 7 CF centres.
Methods: Since July 2011 the Robert Debre´ CF team who has in charge 162 patients
(1m− 22 y) has set up a local QIP Steering Committee (SC) including a “quality
referent” (MD), a psychologist, a nurse, a dietetician, a physiotherapist and a
parent. A methodology guide included an initial step with the “5P” analysis
(Purpose, Professionals, Patients, Process, Patterns), followed by the selection
of an improvement theme. Communication between pilot centres involved Web
collaborative environment (Base Camp), local meetings, meetings with a coach,
participation in learning collaborative sessions through Webex and face-to-face, one
benchmarking visit at the “High results” Centre and lastly evaluation of the QIP.
Conclusion: The improvement theme has been deﬁned with the national registry
database 2009 which identiﬁed a lower median FEV1 (77%) in our 13−17 y cohort
(n = 44) compared to the national value (82.2%). Thus, the multi-disciplinary team
decided to focus on patients 11−17 y.o with FEV1 <80% (n = 22) to identify
individual and common factors that may affect the respiratory function and set up
individual and common action plans. Data on, outcomes, satisfaction and QIP eval-
uation will be available by June 2012.
281 Working towards an age appropriate annual review
V. Thoppil1, M. Kumar1, R. Ross-Russell1, C. Saward1, D. McShane1, R. Iles1.
1Addenbrookes Hospital, Cambridge University, Paediatric Cystic Fibrosis Unit,
Cambridge, United Kingdom
Objectives:
1. To record the age distribution of abnormal annual review blood results for a
CF Centre for last 5 years.
2. To apportion an absolute risk, and suggest an “age appropriate” annual review.
3. To examine the monitory savings.
Methods: The UK Paediatric CF annual review is a detailed assessment of every
aspect of the patient’s treatment and condition. Standards of care have improved
since it was ﬁrst outlined in 1974. This region has screened for CF for 25 years,
ensuring early identiﬁcation, and treatment for the majority of infants. We reviewed
261 annual review records of 53 children with cystic ﬁbrosis, aged 1−15 years
for the years 2007 to 2011. We recorded the number of results that were outside
the normal reference range. An absolute risk (AR) of an abnormal result was then
calculated for test and each year of age. The clinic was then able to make informed
decisions regarding the diagnostic utility of each investigation.
Results: The AR for an abnormal Hb, Na, K, Ca, Ur, Mg, Alkaline phos, and
cholesterol was between 0 and 6% for all age groups. The AR for WBC, Plts,
liver function, bilirubin and coagulation, immunoglogulins, IgE, and vitamin levels
were above 6% for the majority of age groups. The number of positive Aspergillus
RASTs increased from the age of 3. We propose an “age appropriate” annual review
based on this clinic population: Age 0−4: LFT, coagulation screen, vitamin levels.
Age 4−16: LFT, coagulation, vitamin levels, IgE and RAST for Aspergillus. Total
whole clinic savings only amounted to €1,200 pa (€20 per patient).
Conclusion: Annual Reviews can be designed to be population and age appropriate,
with limited ﬁnancial return.
